Trial intelligence / Profile preview

Sulfur vs Permethrin Regimens for Scabies

NCT06396507Phase 3Completed

Sponsor
Damascus University
Start
Mar 2022
Primary completion
Sep 2022
Modality
Nanoparticles, Allosteric Modulators
Countries
1
01

Overview

Phase 3, randomised, open-label trial of permethrin and sulfur ointment in scabies (5 arms), sponsored by Damascus University. Primary endpoint: Clinical Recovery at 28 days. Started Mar 2022; status: completed.

02

Drugs

permethrinsulfur ointment
03

Conditions

scabies

Beyond the preview

Go deeper on NCT06396507.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06396507.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call